Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats

Life Sciences

Volumn 74, Issue 11, 2004, Pages 1375-1386

  Pereira, Leila Maria Meirelles ^a   Almeida, Jorge Reis ^a   Mandarim De Lacerda, Carlos Alberto ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiotensin converting enzyme inhibitor; Hypertension; Nitric oxide; Renal cortex; Stereology

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS; KIDNEY ADAPTATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY TUBULE; MALE; NONHUMAN; PROTEINURIA; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; STEREOLOGY;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0346099152     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.08.015     Document Type: Article

References (52)

1. Abdel-Wahab N., Weston B.S., Roberts T., Mason R.M. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. Journal of the American Society of Nephrology. 13:2002;2437-2445.
2. Almeida J.R., Mandarim-de-Lacerda C.A. Quantitative study of the comma-shaped body, S-shaped body and vascularized glomerulus in the second and third human gestational trimesters. Early Human Development. 69:2002;1-13.
3. Alt J.M., Hackbarth H., Deerberg F., Stolte H. Proteinuria in rats in relation to age-dependent renal changes. Laboratory Animals. 14:1980;95-101.
4. Anderson B.B. The role of nephrons mass and intraglomerular pressure in initiation and progression of experimental hypertensive-renal disorders. Laragh J.H., Brenner B. Hypertension: pathophysiology, diagnosis and management. 1995;1553-1568 Raven Press, New York.
5. Anderson S., Brenner B.M. The role of nephrons mass and intraglomerular pressure in initiation and progression of experimental hypertensive-renal disorders. Laragh J.H., Brenner B.M. Hypertension: pathophysiology, diagnosis and management. 1995;1553-1568 Raven Press, New York.
6. Anderson S., Rennke H.G., Brenner B.M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation. 77:1986;1993-2000.
7. Arcos M.I., Fujihara C.K., Sesso A., Prado E.B.A., Prado M.J.A., Nucci G., Zatz R. Mechanisms of albuminuria in the chronic nitric oxide inhibition model. American Journal of Physiology Renal Physiology. 279:2000;F1060-F1066.
8. Barajas L. Anatomy of the juxtaglomerular apparatus. American Journal of Physiology Renal Physiology. 237:1979;F333-F343.
9. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. Journal of Clinical Investigation. 90:1992;278-281.
10. Bertram J.F., Young R.J., Spencer K., Gordon I. Quantitative analysis of the developing rat kidney: absolute and relative volumes and growth curves. Anatomical Record. 258:2000;128-135.
11. Brenner B.M., Garcia D.L., Anderson S. Glomeruli and blood pressure. Less of one, more the other? American Journal of Hypertension. 1:1988;335-347.
12. Caetano E.R., Zatz R., Saldanha L.B., Praxedes J.N. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension. 38:2001;171-176.
13. Carson F.L., Martin J.H., Lynn J.A. Formalin fixation for electron microscopy: a re-evaluation. American Journal of Clinical Pathology. 59:1973;365-373.
14. Chappell M.C., Iyer S.N., Diz D.I., Ferrario C.M. Antihypertensive effects of angiotensin-(1-7). Brazilian Journal of Medical and Biological Research. 31:1998;1205-1212.
15. Charpie J.R., Charpie P.M., Goud C., Pitt B., Webb R.C. Quinapril prevents hypertension and enhanced vascular reactivity in nitroarginine-treated rats. Blood Pressure. 6:1997;117-124.
16. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney International. 46:1994;1223-1241.
17. Gilbert R.E., Cox A., Wu L.L., Allen T.J., Hulthen U.L., Jerums G., Cooper M.E. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes. 47:1998;414-422.
18. Gilbert R.E., Wu L.L., Kelly D.J., Cox A., Wilkinson-Berka J.L., Johnston C.I., Cooper M.E. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. American Journal of Pathology. 155:1999;429-440.
19. Granger J.P., Schnackenberg C.G. Renal mechanisms of angiotensin II-induced hypertension. Seminars of Nephrology. 20:2000;417-425.
20. Ito S., Carretero O.A., Abe K. Role of nitric oxide in the control of glomerular microcirculation. Clinical and Experimental Pharmacology and Physiology. 24:1997;578-581.
21. Kost C.K. Jr., Li P., Williams D.S., Jackson E.K. Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats. Journal of Cardiovascular Pharmacology. 31:1998;854-861.
22. Kriz W., Hosser H., Hahnel B., Gretz N., Provoost A.P. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrology Dialysis and Transplantation. 13:1998;2781-2798.
23. Kurtz A., Wagner C. Cellular control of renin secretion. Journal of Experimental Biology. 202(Pt. 3):1999;219-225.
24. Langham R.G., Kelly D.J., Cox A.J., Thomson N.M., Holthofer H., Zaoui P., Pinel N., Cordonnier D.J., Gilbert R.E. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia. 45:2002;1572-1576.
25. Mandarim-de-Lacerda C.A. What is the interest of normal and pathological morphological research to be quantitative? The example of the stereology. Brazilian Journal of Morphological Science. 16:1999;131-139.
26. Mandarim-de-Lacerda C.A., Pereira L.M.M. Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-converting enzyme inhibitor and calcium channel blocker. Journal of Cellular and Molecular Medicine. 5:2001;276-283.
27. Nagata M., Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney International. 42:1992;148-160.
28. Nakamura Y., Ono H., Zhou X., Frohlich E.D. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L-arginine methyl ester/spontaneously hypertensive rats. Hypertension. 37:2001;1262-1267.
29. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry. 269:1994;13725-13728.
30. Nyengaard J.R. Stereologic methods and their application in kidney research. Journal of American Society of Nephrology. 10:1999;1100-1123.
31. Nyengaard J.R., Bendtsen T.F. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anatomical Record. 232:1992;194-201.
32. Pagtalunan M.E., Drachman J.A., Meyer T.W. Methods for estimating the volume of individual glomeruli. Kidney International. 57:2000;2644-2649.
33. Pereira L.M., Mandarim-de-Lacerda C.A. Glomerular profile numerical density per area and mean glomerular volume in rats submitted to nitric oxide synthase blockade. Histology and Histopathology. 16:2001;15-20.
34. Person P.B. Nitric Oxide in the kidney. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 283:2002;R1005-R1007.
35. Peterson T.V., Emmeluth C., Bie P. Renal effects of nitric oxide synthase inhibition in conscious water-loaded dogs. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 281:2001;R584-R590.
36. Remuzzi G., Bertani T. Pathophysiology of progressive nephropathies. New England Journal of Medicine. 339:1998;1448-1456.
37. Ribeiro M.O., Antunes E., Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 20:1992;298-303.
38. Rizzoni D., Castellano M., Porteri E., Bettoni G., Muiesan M.L., Cinelli A., Rosei E.A. Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 26:1995;118-123.
39. Rizzoni D., Porteri E., Bettoni G., Piccoli A., Castellano M., Muiesan M.L., Pasini G., Guelfi D., Rosei E.A. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 32:1998;798-806.
40. Rizzoni D., Porteri E., Piccoli A., Castellano M., Bettoni G., Muiesan M.L., Pasini G., Guelfi D., Mulvany M.J., Agabiti Rosei E. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension. 32:1998;305-310.
41. Rosnes J.S., Valego N., Wang J.J., Perez F.M., Rose J.C. Renal mRNA response to reduced perfusion pressure conserved despite denervation in mature ovine fetuses. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 280:2001;R1830-R1836.
42. Sharp P.E., La Regina M.C. The Laboratory Rat. 1998;CRC Press, Boca Raton.
43. Seikaly M.G., Arant B.S. Jr., Seney F.D. Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. Journal of Clinical Investigation. 86:1990;1352-1357.
44. Stocker S.D., Sved A.F., Stricker E.M. Role of renin-angiotensin system in hypotension-evoked thirst: studies with hydralazine. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 279:2000;R576-R585.
45. Susic D. Renal protective potential of antihypertensive drugs. Expert Opinion on Investigating Drugs. 9:2000;2593-2600.
46. Susic D., Frohlich E.D. Nephroprotective effect of antihypertensive drugs in essential hypertension. Journal of Hypertension. 16:1998;555-567.
47. Taugner R., Buhrle C.P., Hackenthal E., Mannek E., Nobiling R. Morphology of the juxtaglomerular apparatus and secretory mechanisms. Contributions to Nephrology. 43:1984;76-101.
48. Verhagen A.M., Koomans H.A., Joles J.A. Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition. European Journal of Pharmacology. 411:2001;175-180.
49. Weir M.R. Diabetes and hypertension: blood pressure control and consequences. American Journal of Hypertension. 12:1999;170S-178S.
50. Zar J.H. Biostatistical analysis. 4th ed. 1999;Prentice-Hall, Upper Saddle River.
51. Zoja C., Corna D., Camozzi D., Cattaneo D., Rottoli D., Batani C., Zanchi C., Abbate M., Remuzzi G. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. Journal of the American Society of Nephrology. 13:2002;2898-2908.
52. Zoja C., Donadelli R., Corna D., Testa D., Facchinetti D., Maffi R., Luzzana E., Colosio V., Bertani T., Remuzzi G. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. American Journal of Kidney Diseases. 29:1997;254-264.